Understanding how HIV-specific B cells recognize antigens to activate immune responses
Antigen recognition and activation of HIV-specific B cell antigen receptors
This study is looking at how certain immune cells called B cells respond to the HIV virus, with the goal of finding ways to boost their activity and help create better vaccines for people at risk of HIV.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Duke University NIH-funded |
| Lab location | 1 site (Durham, United States) |
| Project ID | NIH-11007935 on NIH RePORTER |
What this research studies
This research investigates the interactions between B cell antigen receptors and HIV antigens to better understand how B cells are activated in response to the virus. The study focuses on the kinetic properties of these interactions, which may influence the effectiveness of B cell responses. By using specialized B cell lines and mouse models, researchers aim to identify the specific conditions that enhance B cell activation and lead to the development of broadly neutralizing antibodies against HIV. This could ultimately inform vaccine design and improve immune responses in individuals at risk for HIV.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals at high risk for HIV infection or those living with HIV who may benefit from improved vaccine strategies.
Not a fit: Patients who are not at risk for HIV or those who have already developed advanced stages of HIV/AIDS may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to more effective vaccines or therapies that enhance the immune response against HIV.
How similar studies have performed: Previous research has shown promise in understanding B cell activation mechanisms, but this specific approach focusing on kinetic interactions is relatively novel.
Where this research is happening
Durham, United States
- Duke University — Durham, United States (Active)
Researchers
- Principal investigator: Alam, S. Munir — Duke University
- Study coordinator: Alam, S. Munir
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.